Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.50 and traded as low as $1.41. Spero Therapeutics shares last traded at $1.45, with a volume of 113,012 shares traded. Analyst Ratings Changes Several equities […]
Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory capacity BOSTON, May 31, 2024 Verve.
Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
The surge in urinary tract infection testing demand is mainly propelled by the increasing worldwide instances of UTIs, the rise in hospital-acquired UTIs, and the preference for home and self-testing
SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.